US Patent 7491383 Compositions having enhanced pharmacokinetic characteristics
Patent 7491383 was granted and assigned to Allergan, Inc. on February, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 17 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
David F. Woodward0
Gyorgy Ambrus0
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+418 characters)
Article
Patent abstract
Compositions comprising a therapeutic component and an efficacy enhancing component, that enhances the pharmacokinetic disposition of the therapeutic component, are disclosed. The therapeutic component may include an alpha-2-adrenergic agonist and the efficacy enhancing component may include fatty acids. In one embodiment, the therapeutic component and the efficacy enhancing component form a complex.
Edits on 26 Jul, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07491383 Compositions having enhanced pharmacokinetic characteristics US Patent 7491383 Compositions having enhanced pharmacokinetic characteristics
Infobox
Patent Number
07491383
Patent Number
7491383
Edits on 14 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 1 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07491383 Compositions having enhanced pharmacokinetic characteristics
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07491383
Date of patent
February 17, 2009
Patent application number
10136240
Date Filed
May 1, 2002
Patent primary examiner
Find more entities like US Patent 7491383 Compositions having enhanced pharmacokinetic characteristics
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
